31
New Horizons in Ophthalmology
From moleculare mechanisms to therapy
New Horizons in Ophthalmology
From moleculare mechanisms to therapy
Department für Augenheilkunde
-
Basisinformation
Datum27.06.2022, 10:00 - 29.06.2022, 14:00HybrideventTübingenSpracheEnglischCME Max12 CME PunkteGebühren abgebührenfreiVeranstalterUniversitätsklinik Tübingen
Department für Augenheilkunde -
VERANSTALTUNGSORT
University of Tübingen, ETN-Grand Lecture Hall
Elfriede-Aulhorn-Str. 5-7
72076 Tübingen, DE -
Programm
Online Participation is free of charge after registration at www.horizons2022.de
MONDAY June 27th 2022
10:00
Welcome by the organisers Marius Ueffing
Ulrich Bartz-SchmidtDiagnostics and Therapy of Ocular Tumors
CHAIRS: Michael Foerster & Ulrich Bartz-Schmidt10:10
Reduction of mortality in uveal melanoma. Dream or reality? Nikolaos E. Bechrakis 10:30
Why is the treatment method not decisive for the metastasis of the malignant choroidal melanoma? Heinrich Heimann 10:50
Uveal melanoma metastasis - still a secret? Daniela Süsskind 11:05
Coffee break 11:35
Clinical challenges in vitreo-retinal lymphoma Vinodh Kakkassery 12:05
Molecular genetics of vitreo-retinal lymphoma Falko Fend 12:30
Advances in systemic treatment of vitreo-retinal lymphoma Christian Junghanß 12:50
Lunch break Diagnostics and Therapy of retinal disease
CHAIRS: Sabine Aisenbrey & Ulrich Bartz-Schmidt14:05
Routine practice patterns - Benefit-risk analysis Focke Ziemssen 14:25
Managing active macular disorders Andreas Stahl 14:45
The german national cohort (NAKO) - importance for ophthalmology Alexandra Schweig 15:00
Retinal functional diagnostics: how to measure therapy success? Katarina Stingl 15:15
Coffee break 15:45
CRAO - clinical management Martin Spitzer 16:05
Limitations, bottlenecks, and new horizons in retina implant ersearch Peter Walter 16:20
Sorapazan: an EU clinical study on Stargardt´s disease Tobias Peters AI Lecture
CHAIRS: Nicole Eter & Marius Ueffing16:35
AI for the Eye Philipp Berens 17:05
CLOSING TALK: Inspiration-Motivation-"Supervision" - The role of organizations in terms of science in retinal research Franz Badura from
18:00RECEPTION@Kerstan Atrium TUESDAY June 28th 2022
Moleculare mechanisms & Therapy development
CHAIRS: Franz Holk & Daniel Pauleikhoff09:00
KEYNOTE LECTURE: Age-related macular degeneration genetics meets genome architecture: a merger in the retina Anand Swaroop 09:30
Nature & nurture in AMD: where is the potential for the patient? Caroline Klaver 09:50
Targeting AMD pathomechanisms for therapy development Sascha Fauser 10:10
Classifying AMD Monika Fleckenstein 10:30
Imaging endpoints in clinical trials in AMD Steffen Schmitz-Valckenberg 10:50
Coffee break Retinal disease and inflammation
CHAIRS: Marius Ueffing & Simon Clark11:20
Intracellular signaling in response to complement stimulation Olaf Strauss 11:40
Mineralocorticoid pathways in the retina Francine Behar-Cohen 12:00
Retinal inflammation and AMD Florian Sennlaub 12:20
The non-canonical function of CFH in RPE cells and AMD Angela Armento 12:30
Removal of RPE lipofuscin as a possible therapy option for Stargardtßs disease and AMD? Sylvie Julien-Schraermeyer 12:50
Molecular mechanisms of uveitis Cornelia Deeg 13:10
Lunch@Kerstan Atrium Molecular Diagnostics & Therapy development
CHAIRS: Irene Maumenee & Bernd Wissinger14:00
Selecting the right patient for gene therapy: reflecting genetic results - a critical discourse and species cases Susanne Kohl 14:15
Gene-therapy, the next steps ahead? Dominik Fischer 14:35
Non-viral transposon-based gene therapy - the efficient alternative approach escaping the immune system Gabriele Thumann 14:55
Precision genome surgery for imprecision medicine Stephen Tsang 15:20
Coffee break Molecular Therapy Development I
CHAIRS: Hendrik Scholl & Francois Paquet-Durand16:00
KEYNOTE LECTURE: Expediting AAV gene therapy Alberto Auricchio 16:30
Restoring vision with gene and cell therapy Deniz Dalkara 16:50
Gene therapy for hearing loss Ellen Reisinger 17:10
Targeting proteostasis as mutation independent pharmacological therapy Blanca Arango-Gonzalez 17:20
Retinitis pigmentosa: using PKG ingibitors tgo prevent photoreceptor cell death Francois Paquet-Durand Molecular Therapy Development II
CHAIRS: Eberhart Zrenner & Mathias Seeliger17:30
Visual restoration Serge Picaud 17:50
Break 18:00
EVENING LECTURE: Optogenetics Botond Roska 19:00
Speakers Dinner @ KELTER WEDNESDAY June 29th 2022
Organoids and cell-based therapy development
CHAIRS: Thomas Euler & Frank Schaeffel09:00
Regenerating human photoreceptors Volker Busskamp 09:20
A glance at the eye in the dish Stefan Liebau 09:40
Combining genome editing and retinal organoids for IRDs Vasiliki Kalatzis 10:00 Towards modelling and rescue of inherited retinal dystrophies using prime editing and patient-derived iPSCs
Peter Quinn 10:20
Functional analysis of the retina Wadood Haq 10:35
Advancing adaptive optics Christina Schwarz 10:50
Coffee break Pathomechanisms of retinal disease
CHAIRS: Knut Stieger & Sven Schnichels11:20
Oxidates stress in AMD pathogenesis Kai Kaarniranta 11:40
Proteostasis in the neuroretina Mike Cheetham 12:00
A systems view on ciliopathies Ronald Roepman 12:20
A mouse model of INPP5E-Leber congenital amaurosis Wolfgang Baehr 12:40
SUMMARY & FAREWELL Ulrich Bartz-Schmidt
Marius Ueffing13:00
Light Lunch @ Kerstan Atrium -
Gebühren
Fachärzte/-innenGebühren abgebührenfreiÄrzte/-innen in WeiterbildungGebühren abgebührenfreiStudenten/-innenGebühren abgebührenfrei
-
Buchung / Anmeldung
Bitte wenden Sie sich für weitere Informationen direkt an den Veranstalter
-
Zertifizierung
Zertifizierung beantragt für 12 CME Punkte bei der Landesärztekammer Baden-Württemberg